Ileal ureteral replacement for the management of ureteral avulsion during ureteroscopic lithotripsy: a case series.

Ileal ureteral replacement Laparoscopy Robot-assisted surgery Ureteral avulsion Ureteral injuries Ureteroscopic lithotripsy

Journal

BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567

Informations de publication

Date de publication:
07 Jul 2022
Historique:
received: 19 01 2022
accepted: 14 06 2022
entrez: 7 7 2022
pubmed: 8 7 2022
medline: 12 7 2022
Statut: epublish

Résumé

To describe our initial experience with ileal ureteral replacement (IUR) for the management of ureteral avulsion (UA) during ureteroscopic lithotripsy. Between September 2010 and April 2021, ten patients received ileal ureteral replacement for ureteral avulsion during ureteroscopic lithotripsy. Anterograde urography and computed tomography urography (CTU) were applied to evaluate the lesion. Follow-up was performed with magnetic resonance urography and renal ultrasound as well as clinical assessment of symptoms. We retrospectively analysed the clinical data of ten patients treated with ileal ureteral replacement for the treatment of ureteral avulsion. Four patients underwent open ileal ureteral replacement, two underwent laparoscopic ileal ureteral replacement, and four underwent robotic-assisted ileal ureteral replacement. The mean operative time (OT) was 310 min (range 191-530). The mean estimated blood loss (EBL) was 193 mL (range 10-1000). The mean length of the ileal graft was 21 cm (range 12-25). The median postoperative hospital time was 13 days (range 7-19). All surgeries were effectively completed, and no case required open conversion in laparoscopic and robotic-assisted surgeries. There was no obvious hydronephrosis according to contrast-enhanced computed tomography 3-dimensional reconstruction images without serious complications or progressive hydronephrosis during a median follow-up duration of 51 months (range 5-131), and the success rate was 100%. Our initial results and experience showed that ileal ureteral replacement for the management of ureteral avulsion during ureteroscopic lithotripsy is safe and feasible.

Identifiants

pubmed: 35799183
doi: 10.1186/s12893-022-01690-0
pii: 10.1186/s12893-022-01690-0
pmc: PMC9264655
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

262

Informations de copyright

© 2022. The Author(s).

Références

J Urol. 2003 Apr;169(4):1363-7
pubmed: 12629362
J Endourol. 2014 Dec;28(12):1470-3
pubmed: 25343358
Eur Urol. 2018 Mar;73(3):419-426
pubmed: 29239749
J Urol. 2017 Dec;198(6):1430-1435
pubmed: 28736319
Int J Med Robot. 2021 Jun;17(3):e2230
pubmed: 33533169
Urology. 2017 Oct;108:201-206
pubmed: 28739403
Urology. 2011 Sep;78(3):692-5
pubmed: 21741686
J Urol. 1959 Mar;81(3):406-18
pubmed: 13642478
IJU Case Rep. 2020 Aug 18;3(6):241-243
pubmed: 33163914
BJU Int. 2013 Jul;112(1):137-55
pubmed: 23759011
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
J Urol. 2009 Sep;182(3):1032-9
pubmed: 19616806
Urolithiasis. 2013 Apr;41(2):183-6
pubmed: 23503882
J Urol. 1999 Aug;162(2):323-6
pubmed: 10411030
J Endourol. 2020 Aug;34(8):874-881
pubmed: 32323579
Eur Urol. 2012 Apr;61(4):764-72
pubmed: 22266271
BMC Surg. 2019 Jan 18;19(1):9
pubmed: 30658620
Arch Ital Urol Androl. 2016 Jul 04;88(2):97-100
pubmed: 27377083
Urology. 2016 Feb;88:201-6
pubmed: 26577622
Urology. 2018 Mar;113:e9-e10
pubmed: 29288787
Br J Urol. 1973 Jun;45(3):328
pubmed: 4712838
BJU Int. 2017 Aug;120(2):273-279
pubmed: 28220579
BJU Int. 2003 Jan;91(2):138-42
pubmed: 12519115
BJU Int. 2015 Feb;115(2):282-7
pubmed: 24471943
BJU Int. 2016 Apr;117(4):648-54
pubmed: 26237735
Urol Clin North Am. 2004 Feb;31(1):157-71
pubmed: 15040412
Urology. 2001 Oct;58(4):540-3
pubmed: 11597534
Urol Clin North Am. 2013 Aug;40(3):351-61
pubmed: 23905933

Auteurs

Changwei Yuan (C)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Zhihua Li (Z)

Department of Nursing, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Jie Wang (J)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Peng Zhang (P)

Department of Urology, Emergency General Hospital, No. 29, Xibahenanli St, Chaoyang District, Beijing, 100028, China.

Chang Meng (C)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Dan Li (D)

Department of Nursing, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Jingjing Gao (J)

Department of Nursing, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Hua Guan (H)

Department of Nursing, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Weijie Zhu (W)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Boyu Lu (B)

Department of Urology, Panjin Liaohe Oilfield Gem Flower Hospital, No. 26, YingBin St, Xinglongtai District, Panjin, 124010, China.

Zhichao Zhang (Z)

Department of Urology, Qinhuangdao Jungong Hospital, No. 15, YuFeng St, Haigang District, 066001, Qinhuangdao, China.

Ninghan Feng (N)

Department of Urology, Affiliated Wuxi No. 2 Hospital, Nanjing Medical University, No. 68, Zhongshan St, Liangxi District, Wuxi, 214001, China.

Kunlin Yang (K)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Xuesong Li (X)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China. pineneedle@sina.com.

Liqun Zhou (L)

Department of Urology, Peking University First Hospital, National Urological Cancer Center, Institute of Urology, Peking University, No. 8 Xishiku St, Xicheng District, Beijing, 100034, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH